Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Sami Corwin is an analyst at William Blair. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/25/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 01/30/2025 | CRGX | Buy Now | Cargo Therapeutics | $4.18 | — | Sami Corwin11% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 12/23/2024 | APLT | Buy Now | Applied Therapeutics | $0.55 | — | Sami Corwin11% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 11/26/2024 | CRGX | Buy Now | Cargo Therapeutics | $4.18 | — | Sami Corwin11% | — | Initiates | → Outperform | Get Alert |
| 06/10/2024 | TNYA | Buy Now | Tenaya Therapeutics | $0.65 | — | Sami Corwin11% | — | Initiates | → Outperform | Get Alert |
| 03/21/2024 | NGNE | Buy Now | Neurogene | $14.21 | — | Sami Corwin11% | — | Initiates | → Outperform | Get Alert |
| 08/04/2023 | MESO | Buy Now | Mesoblast | $14.05 | — | Sami Corwin11% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 05/30/2023 | CRSP | Buy Now | CRISPR Therapeutics | $40.90 | 83.37% | Sami Corwin11% | → $75 | Reinstates | → Outperform | Get Alert |
| 05/25/2023 | LEGN | Buy Now | Legend Biotech | $34.56 | — | Sami Corwin11% | — | Initiates | → Market Perform | Get Alert |
| 10/19/2022 | AKUS | Buy Now | Akouos | — | — | Sami Corwin11% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 09/29/2022 | AKUS | Buy Now | Akouos | — | — | Sami Corwin11% | → $12 | Initiates | → Outperform | Get Alert |
| 10/27/2021 | QURE | Buy Now | uniQure | $14.23 | 363.81% | Sami Corwin11% | → $66 | Initiates | → Outperform | Get Alert |
